The analysis of the tumor inflammatory microenvironment composition in DLBCL patients revealed the significant increased number of CD163+ cells in the ABC group of patients and a positive correlation between CD163+ cells and STAT3 expression in tumor cells [41]. The gene discussed is CD163; the disease is neoplasm.